Personalized discharge letters may ease worry for Low-Risk skin cancer patients
NCT ID NCT07330323
First seen Jan 11, 2026 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This study tests whether giving low-risk skin cancer patients a personalized discharge letter after screening helps them feel more reassured and understand their risk better. About 150 patients will be split into groups: standard care, a generic letter, or a personalized letter created by an AI tool and reviewed by a doctor. The goal is to see if tailored information improves confidence and reduces unnecessary follow-up visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UZLeuven, Department of Dermatology
Leuven, Vlaams-Brabant, 3000, Belgium
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.